Volume 95, Issue 1, Pages (January 2019)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury  Fatime Geyikoglu,
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 94, Issue 3, Pages (September 2018)
Volume 80, Issue 7, Pages (October 2011)
Volume 85, Issue 1, Pages (January 2014)
Volume 65, Issue 2, Pages (February 2004)
Volume 65, Issue 5, Pages (May 2004)
Hatem Elabd, Rushi Nayak, Tarek Rashid, M. Barry Stokes 
Volume 85, Issue 4, Pages (April 2014)
Vivette D D'Agati, MD, Agnes B Fogo, MD, Jan A Bruijn, MD, J
Volume 93, Issue 1, Pages (January 2018)
Volume 92, Issue 2, Pages (August 2017)
Volume 72, Issue 6, Pages (September 2007)
Volume 76, Issue 5, Pages (September 2009)
Volume 68, Issue 3, Pages (September 2005)
Volume 85, Issue 6, Pages (June 2014)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 69, Issue 10, Pages (May 2006)
Volume 65, Issue 1, Pages (January 2004)
Volume 66, Issue 6, Pages (December 2004)
Lithium-associated nephropathy in the renal allograft
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 77, Issue 4, Pages (February 2010)
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
Volume 5, Issue 2, Pages (August 2015)
Volume 59, Issue 1, Pages (January 2001)
Volume 77, Issue 11, Pages (June 2010)
Volume 69, Issue 1, Pages (January 2006)
Volume 54, Issue 6, Pages (January 1998)
Volume 79, Issue 6, Pages (March 2011)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Nrf2-deficient female mice develop lupus-like autoimmune nephritis1
Renal phenotype is exacerbated in Os and lpr double mutant mice
The spectrum of kidney biopsy findings in patients with morbid obesity
Volume 71, Issue 1, Pages (January 2007)
Atubular glomeruli in a rat model of polycystic kidney disease
Volume 63, Issue 4, Pages (April 2003)
G.S. Markowitz, C. Gelber, V.D. D'agati  Kidney International 
Volume 59, Issue 4, Pages (April 2001)
Volume 95, Issue 3, Pages (March 2019)
Volume 79, Issue 6, Pages (March 2011)
Volume 86, Issue 6, Pages (December 2014)
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
Gas in a renal allograft: think beyond!
Volume 95, Issue 3, Pages (March 2019)
Volume 64, Issue 1, Pages (July 2003)
Obesity-related glomerulopathy: An emerging epidemic
Volume 78, Issue 11, Pages (December 2010)
Hypertension, race, and glomeruli: more than simply a numbers game
Volume 74, Issue 6, Pages (September 2008)
Volume 54, Issue 3, Pages (September 1998)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 56, Issue 5, Pages (November 1999)
Volume 67, Issue 3, Pages (March 2005)
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
Volume 72, Issue 10, Pages (November 2007)
Volume 92, Issue 4, (October 2017)
Harold M. Aukema, Ihsan Housini  Kidney International 
Volume 58, Issue 5, Pages (November 2000)
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Volume 73, Issue 9, Pages (May 2008)
Volume 68, Issue 4, Pages (October 2005)
Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis  Gary S. Hill, Michel Delahousse,
Volume 67, Issue 3, Pages (March 2005)
Volume 73, Issue 5, Pages (March 2008)
Growing a new human kidney
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Volume 79, Issue 11, Pages (June 2011)
Presentation transcript:

Volume 95, Issue 1, Pages 57-61 (January 2019) Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice  Tomoko Takano, Eric Bareke, Naoki Takeda, Lamine Aoudjit, Cindy Baldwin, Philip Pisano, Jun Matsuda, Jasmine El Andalousi, Lina Muhtadie, Chantal Bernard, Jacek Majewski, Toru Miyazaki, Ken-ichi Yamamura, Indra R. Gupta  Kidney International  Volume 95, Issue 1, Pages 57-61 (January 2019) DOI: 10.1016/j.kint.2018.08.014 Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 1 Whole exome sequencing (WES) identified a homozygous frameshift mutation in the CD2AP gene. (a) Pedigree of the affected family. Three siblings (2 males and 1 female) born to consanguineous parents of Lebanese origin (first cousins) developed focal segmental glomerulosclerosis (FSGS) in their teens and had progression to end-stage renal disease by ∼20 years of age. (b) Kidney biopsy of brother 2 (left) and sister (right) showing FSGS. Top left: Masson’s trichrome staining shows a glomerulus with early segmental lesion (arrow) and a normal glomerulus (asterisk). Bar = 100 nm. Bottom left: Periodic acid-Schiff (PAS) staining shows a hypertrophic (asterisk) as well as a globally sclerosed (arrow) glomerulus with a few adjacent atrophic tubules (arrow). Bar = 80 nm. Top right: Silver staining shows an enlarged glomerulus with a well-developed segmental sclerosing lesion with a capsular adhesion (asterisk). The adjacent glomeruli show some thickening of the Bowman’s capsule (arrows). Bar = 70 nm. Bottom right: PAS staining shows 2 well-preserved glomeruli, except for early capsular adhesion (arrow). Bar = 90 nm. (c) WES identified an insertion of 4 nucleotides in the CD2AP gene that causes a frameshift at S198, resulting in a stop codon (p.S198fs). Sanger sequencing confirmed that all 3 siblings were homozygous for the mutation while the unaffected father was heterozygous. (d) Expected protein structures of the wild type (WT) and S198fs. CC, coiled-coil domain; SH3, Src homology 3 domain. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2019 95, 57-61DOI: (10.1016/j.kint.2018.08.014) Copyright © 2018 International Society of Nephrology Terms and Conditions

Figure 2 Cd2ap knock-in mice for S198fs develop heavy proteinuria and die of kidney failure. p.Ser198fs mutation was introduced into the mouse embryonic stem cells by using CRISPR/Cas9 gene editing, and knock-in mice were generated (C57BL/6). When heterozygous mice carrying the insertion were bred, wild-type (WT), heterozygous (Het), and homozygous (Homo) mice were born at the expected Mendelian frequency. (a) Urine gel electrophoresis and Coomassie Blue staining of 2-week-old mice. Homo mice showed heavy albuminuria. (b) By 4 weeks, elevated blood urea nitrogen (BUN), serum creatinine (sCr), and hypoalbuminemia (sAlb) levels were observed. These changes were not seen in heterozygotes or WT. Homo mice died at ∼6–8 weeks of kidney failure. n = 3–5 mice each. ∗P < 0.05, **P < 0.01 vs. WT and Het. (c) Histological changes in the kidney of knock-in mice. PAS staining of the kidneys. By 2–3 weeks, Homo mice showed mild glomerulosclerosis, tubular atrophy, and interstitial leukocyte infiltration. By 4–6 weeks, histological changes worsened. These changes were not seen in heterozygotes or WT. See Supplementary Figure S1 for quantification. BSA, bovine serum albumin. Bar = 50 μm. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2019 95, 57-61DOI: (10.1016/j.kint.2018.08.014) Copyright © 2018 International Society of Nephrology Terms and Conditions